Clinical Trials · NCT00505882
Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 Diabetes
- Phase
- Phase 4
- Recruitment status
- Withdrawn
- Sponsor
- University of Texas Southwestern Medical Center
- Enrollment
- 0
- Start date
- Jul 2007
- Locations
- 1 site, United States
- Primary endpoint
- The change in weight (kg) will be compared between as well as within the placebo and the pramlintide treatment group from baseline to the end of the study.